Skip to main content

Table 2 Demographic, clinical, and psychosocial characteristics of patients according to their PTG levels over time

From: Posttraumatic growth and well-being among adolescents and young adults (AYAs) with cancer: a longitudinal study

  High PTG
N = 73 (44.8%)
Increasing PTG
N = 23 (14.1%)
Low PTG
N = 44 (27.0%)
Decreasing PTG
N = 23 (14.1%)
p value
Sociodemographic and clinical characteristics
Sex      0.011
 Female 43 (58.9%) 9 (39.1%) 18 (40.9%) 5 (21.7%)  
 Male 30 (41.1%) 14 (60.9%) 26 (59.1%) 18 (78.3%)  
Race      0.82
 White 31 (43.1%) 10 (43.5%) 21 (47.7%) 13 (59.1%)  
 Hispanic/Latino 33 (45.8%) 11 (47.8%) 17 (38.6%) 8 (36.4%)  
 Other 8 (11.1%) 2 (8.7%) 6 (13.6%) 1 (4.5%)  
Relationship status over time      0.29
 Relationship at all time points 16 (21.9%) 5 (21.7%) 7 (15.9%) 8 (36.4%)  
 No relationship at any time point 38 (52.1%) 13 (56.5%) 29 (65.9%) 7 (31.8%)  
 Fluctuating 19 (26.0%0 5 (21.7%) 8 (18.2%) 7 (31.8%)  
Educational level 24-month follow-up      0.064
 Less than high school 28 (51.9%) 6 (31.6%) 10 (26.3%) 3 (17.6%)  
 High school graduate 10 (18.5%) 5 (26.3%) 8 (21.1%) 3 (17.6%)  
 Some college 8 (14.8%) 4 (21.1%) 11 (28.9%) 9 (52.9%)  
 College graduate or above 8 (14.8%) 4 (21.1%) 9 (23.7%) 2 (11.8%)  
Occupational status over time      0.67
 Job/school at all time points 34 (47.2%) 8 (34.8%) 17 (38.6%) 7 (30.4%)  
 No job/school at any time point 15 (20.8%) 7 (30.4%) 8 (18.2%) 6 (26.1%)  
 Fluctuating 23 (31.9%) 8 (34.8%) 19 (43.2%) 10 (43.5%)  
Age at diagnosis, years      
 Mean (SD) 21.9 (8.9) 23.7 (9.0) 22.2 (8.6) 27.7 (8.8) 0.046
 14–17 41 (56.2%) 10 (43.5%) 21 (47.7%) 3 (13.0%) 0.009
 18–25 8 (11.0%) 4 (17.4%) 11 (25.0%) 9 (39.1%)  
 26–39 24 (32.9%) 9 (39.1%) 12 (27.3%) 11 (47.8%)  
Severity of cancer by survival rate      0.78
 <50% 24 (32.9%) 8 (34.8%) 16 (36.4%) 4 (17.4%)  
 50–80% 27 (37.0%) 9 (39.1%) 17 (38.6%) 10 (43.5%)  
 >80% 22 (30.1%) 6 (26.1%) 11 (25.0%) 9 (39.1%)  
Type of treatment (cumulative)      0.034
 Receiving chemotherapy 70 (100%) 21 (91.3%) 39 (88.6%) 20 (87.0%) 0.82
 Receiving radiation 16 (26.2%) 6 (28.6%) 8 (20.0%) 6 (35.3%) 0.58
 Surgical treatment 44 (65.7%) 15 (75.0%) 26 (63.4%) 17 (85.0%)  
Treatment status over time      0.29
 On treatment at all time points 16 (21.9%) 5 (21.7%) 7 (15.0%) 8 (36.4%)  
 Off treatment at all time points 38 (52.1%) 13 (56.5%) 29 (65.9%) 7 (31.8%)  
 Fluctuating 19 (26.0%) 5 (21.7%) 8 (18.2%) 7 (31.8%)  
Number of symptoms baseline      0.34
 Mean 5.5 (2.4) 4.6 (3.0) 4.9 (2.4) 4.8 (2.8)  
Number of symptoms 24-month follow-up      0.81
 Mean (SD) 3.0 (2.9) 2.9 (2.3) 3.4 (2.7) 2.7 (2.6)  
Total social support baseline mean (SD) 82.2 (15.6) 75.9 (18.9) 79.1 (14.8) 80.4 (16.1) 0.40